Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery
Conditions
- Recurrent Melanoma
- Stage IIA Melanoma
- Stage IIB Melanoma
- Stage IIC Melanoma
- Stage IIIA Melanoma
- Stage IIIB Melanoma
- Stage IIIC Melanoma
- Stage IV Melanoma
Interventions
- DRUG: Montanide ISA 51 VG
- BIOLOGICAL: MART-1 antigen
- OTHER: laboratory biomarker analysis
- BIOLOGICAL: Gag:267-274 peptide vaccine
- DRUG: resiquimod
Sponsor
Mayo Clinic
Collaborators